These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37350425)

  • 1. Thoracic SMARCA4-deficient undifferentiated tumor with associated granulomatous reaction and response to pembrolizumab.
    Marshall M; Khader S; Beasley S; Lajara S
    Diagn Cytopathol; 2023 Oct; 51(10):E287-E293. PubMed ID: 37350425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.
    Kito Y; Kawashima K; Saigo C; Hasegawa M; Nomura S; Mikamo T; Hanamatsu Y; Matsuo Y; Takeuchi T
    Diagn Pathol; 2022 Feb; 17(1):29. PubMed ID: 35151345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thoracic
    Xiong Y; Zhang B; Nie LG; Wu SK; Zhao H; Li D; DI JT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):351-356. PubMed ID: 37042149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Under the Microscope: A Case Report of Thoracic SMARCA4-Deficient Undifferentiated Tumor with Review of the Literature.
    Mundada M; Mannan KA; Vasu D; Ahmed F; K S
    Turk Patoloji Derg; 2024; 40(2):128-133. PubMed ID: 38265099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thoracic SMARCA2-deficient But SMARCA4-preserved Tumors With Undifferentiated Morphology Combined With Claudin-4 Negativity.
    Iwakoshi A; Sasaki E; Sato M; Sugiyama K; Kogure Y; Kitagawa C; Nishimura R
    Am J Surg Pathol; 2022 Jul; 46(7):1000-1006. PubMed ID: 35220352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
    Wang WN; Liu XT; Liang YM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
    [No Abstract]   [Full Text] [Related]  

  • 7. Thoracic SMARCA4-deficient undifferentiated tumor: A clinicopathological and prognostic analysis of 35 cases and immunotherapy efficacy.
    Zhou P; Fu Y; Tang Y; Jiang L; Wang W
    Lung Cancer; 2024 Mar; 189():107471. PubMed ID: 38306886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoracic SMARCA4-deficient undifferentiated tumor.
    Jiang J; Chen Z; Gong J; Han N; Lu H
    Discov Oncol; 2023 Apr; 14(1):51. PubMed ID: 37115343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of tislelizumab when combined with etoposide and carboplatin in patients with SMARCA4-deficient undifferentiated thoracic tumor: a case report.
    Yang P; Xiong F; Lin Y; Liang P; Tang C
    Transl Cancer Res; 2023 Apr; 12(4):1041-1048. PubMed ID: 37180644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed Diagnosis of SMARCA4-Deficient Undifferentiated Tumor in a Heavy Smoker Male Patient: Discovered Through Bone Sampling, with Extensive Distant Metastases and Concurrent Granulomatous Disease, Leading to Patient Fatality.
    Shaker N; Ben Musa R; Tynski Z; Shaker N; Sangueza OP; Boyd B
    Int J Surg Pathol; 2024 Jun; ():10668969241260215. PubMed ID: 38899907
    [No Abstract]   [Full Text] [Related]  

  • 11. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.
    Sauter JL; Graham RP; Larsen BT; Jenkins SM; Roden AC; Boland JM
    Mod Pathol; 2017 Oct; 30(10):1422-1432. PubMed ID: 28643792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoracic SMARCA4-deficient undifferentiated tumor-a case of an aggressive neoplasm-case report.
    Roden AC
    Mediastinum; 2021; 5():39. PubMed ID: 35118344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report.
    Kunimasa K; Okami J; Takenaka S; Honma K; Kukita Y; Nagata S; Kawamura T; Inoue T; Tamiya M; Kuhara H; Nishino K; Tahara H; Kumagai T
    JTO Clin Res Rep; 2021 Nov; 2(11):100235. PubMed ID: 34746887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Rare Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor With Diffuse Brain Metastasis.
    Chan SH; Dagat LAM; Latif N
    Cureus; 2024 May; 16(5):e61367. PubMed ID: 38947666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of surgically treated non-metastatic SMARCA4-deficient undifferentiated thoracic tumor: a case report and literature review.
    Yin C; Liu ZJ; He C; Yu HX
    Front Oncol; 2024; 14():1399868. PubMed ID: 38903719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities.
    Yoshida A; Kobayashi E; Kubo T; Kodaira M; Motoi T; Motoi N; Yonemori K; Ohe Y; Watanabe SI; Kawai A; Kohno T; Kishimoto H; Ichikawa H; Hiraoka N
    Mod Pathol; 2017 Jun; 30(6):797-809. PubMed ID: 28256572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMARCA4-Deficient Undifferentiated Tumor of Lung Mass-A Rare Tumor With the Rarer Occurrence of Brain Metastasis: A Case Report and Review of the Literature.
    Yadav R; Sun L; Salyana M; Eric M; Gotlieb V; Wang JC
    J Investig Med High Impact Case Rep; 2022; 10():23247096221074864. PubMed ID: 35356840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature.
    Stewart BD; Kaye F; Machuca T; Mehta HJ; Mohammed TL; Newsom KJ; Starostik P
    Int J Surg Pathol; 2020 Feb; 28(1):102-108. PubMed ID: 31382829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMARCA4-Deficient Undifferentiated Tumor of the Esophagus: Diagnostic Pitfalls in Immunohistochemical Profiles.
    Chakrabarti R; Lin S; Wang H; Cecchini M
    Int J Surg Pathol; 2024 Oct; 32(7):1292-1302. PubMed ID: 38497146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: A rapid response to immunotherapy in a thoracic SMARCA4-deficient undifferentiated tumor with respiratory failure.
    Shi L; Lin L; Ding Y; Zeng Y; Chen X
    Front Oncol; 2022; 12():1020875. PubMed ID: 36452500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.